InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,421.03
(
0.85%
)
US TECH 100
19,104.80
(
0.73%
)
Dow Jones
38,712.21
(
0.00%
)
Brent Oil
81.97
(
-0.41%
)
Bitcoin
67,859.65
(
-0.56%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12466
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Friday, 09/16/2011 11:28:44 AM

Friday, September 16, 2011 11:28:44 AM

Post# of 80490
Well, tell Forbes that Ziopharm's advanced sarcoma drug is not in early stage development (although, it may be a different compound than what is discussed here)

http://www.forbes.com/sites/genemarcial/2011/07/06/ziopharm-oncology-why-this-tiny-biotech-has-attracted-fidelity-and-other-big-investors/
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up